FINWIRES · TerminalLIVE
FINWIRES

Equinor Starts Eirin Field, Boosts European Gas Supply

作者

-- Equinor (EQNR) has brought the Eirin field online, unlocking about 27.6 million barrels of oil equivalent in recoverable resources, mainly gas, to support European supply, the company said in a Tuesday statement.

The company is exporting gas from Eirin through the Gina Krog and Sleipner A platforms in the North Sea, strengthening flows from Norway to Europe, Equinor said.

Equinor developed the subsea field in about three years from project launch to production start, the company noted.

The company discovered Eirin in 1978 but shelved the project due to weak economics, then reassessed the field in 2023 as demand for Norwegian gas increased after Russia's invasion of Ukraine, it said.

Equinor invested about 4.5 billion Norwegian kroner ($486.5 million) to develop the field, tying the subsea facility back to the Gina Krog platform and exporting gas via the Sleipner hub.

The project will extend the Gina Krog platform's operational life to 2036 from 2029, supporting continued production and preserving associated jobs.

Equinor electrified the Gina Krog platform in 2023, enabling low emissions from Eirin, with a carbon intensity of about 3 kilograms of CO2 per barrel of oil equivalent produced.

"The partnership saw an opportunity to contribute to Europe's energy security in a challenging time. We made an ambitious plan for a fast, cost effective and safe development," Linda Kada Hoiland, senior vice president at Equinor, said.

"Eirin will extend production from the Gina Krog platform by seven years," Hoiland said, adding that the project will deliver gas to Europe while supporting value creation and jobs linked to the asset.

Price: $41.57, Change: $+0.25, Percent Change: +0.61%

相關文章

Australia

布倫瑞克公司維持季度股利每股0.44美元,將於6月15日支付給5月18日登記在冊的股東。

Price: $78.25, Change: $+3.79, Percent Change: +5.09%

$BC
Australia

Ero Copper 的評級從“與行業持平”上調至“跑贏大盤”,National Bk 認為其自由現金流前景良好,且“相對不受持續成本壓力的影響”。

Price: $34.47, Change: $+1.12, Percent Change: +3.36%

$ERO.TO
Australia

奧本海默稱,Vertex製藥公司對其新興的腎臟業務充滿信心

奧本海默週二發布的一份報告指出,Vertex Pharmaceuticals (VRTX) 的管理層對其新興的腎臟疾病治療產品線充滿信心,並表示該產品線最終可能與囊性纖維化治療產品線相媲美,甚至超越後者。 報告稱,Alyftrek 的強勁市場接受度令人鼓舞,奧本海默預計,在美國和國際市場,Alyftrek 將繼續增長,這主要得益於初治患者、此前停止囊性纖維化治療的患者以及轉用 Alyftrek 的患者群體的積極採用。 報告還指出,Alyftrek 在年輕患者群體中的普及以及在歐洲市場更廣泛的應用,應有助於其長期成長。此外,該券商表示,Journavx 的管理層仍有信心在 2026 年實現處方總量的三倍成長。 報告稱,管理層對 Pove 的前景充滿信心,並且 Pove 近期已完成提交,這表明 FDA 可能在年底前做出決定。 奧本海默表示,Inaxaplin是下一個關鍵催化劑,其2期AMPLIFIED研究結果預計將於下半年公佈,而先前的預期為2026年中期。 奧本海默維持對Vertex Pharmaceuticals的「跑贏大盤」評級,目標價為600美元。Price: $423.92, Change: $-5.93, Percent Change: -1.38%

$VRTX